These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21953756)

  • 41. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
    Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
    Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Recanalization of a short occlusion of the popliteal artery using the Simpson atherectomy catheter].
    Lugmayr H
    Acta Med Austriaca; 1989; 16(2):32-4. PubMed ID: 2526448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined intraoperative iliac artery stents and femoro-popliteal bypass for multilevel atherosclerotic occlusive disease.
    Liu C; Guan H; Li Y; Zheng Y; Liu W
    Chin Med Sci J; 2001 Sep; 16(3):165-8. PubMed ID: 12899330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late reobstruction in iliac arterial stents: percutaneous treatment.
    Vorwerk D; Guenther RW; Schürmann K; Wendt G
    Radiology; 1995 Nov; 197(2):479-83. PubMed ID: 7480697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years.
    Iida O; Nanto S; Uematsu M; Ikeoka K; Okamoto S; Nagata S
    JACC Cardiovasc Interv; 2009 Jul; 2(7):665-71. PubMed ID: 19628191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment paradigms for the superficial femoral artery: are they a-changin?
    Scheinert D
    JACC Cardiovasc Interv; 2012 Mar; 5(3):339-40. PubMed ID: 22440501
    [No Abstract]   [Full Text] [Related]  

  • 49. [Secondary Simpson atherectomy of femoro-popliteal obstructions. Alternative or supplementary procedure to the femoral stent?].
    Küffer G; Walter I; Spengel F; Steckmeier B; Schmölder A
    Vasa Suppl; 1992; 35():187. PubMed ID: 1481041
    [No Abstract]   [Full Text] [Related]  

  • 50. Commentary on "Crossing chronic total occlusions of the iliac and femoral-popliteal vessels and the use of true lumen reentry devices".
    Shafique S
    Perspect Vasc Surg Endovasc Ther; 2006 Mar; 18(1):37-8. PubMed ID: 16628328
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of "cutting" balloon angioplasty for the treatment of short femoral bifurcation steno-obstructive disease.
    Cotroneo AR; Iezzi R
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):921-8. PubMed ID: 20098989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Commentary: The ENABLER-P Balloon Catheter System: a new and exciting tool for recanalization of femoropopliteal CTOs.
    Setacci C; Sirignano P; Setacci F
    J Endovasc Ther; 2012 Apr; 19(2):140-3. PubMed ID: 22545875
    [No Abstract]   [Full Text] [Related]  

  • 53. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: midterm outcomes.
    Stricker H; Jacomella V
    J Endovasc Ther; 2004 Jun; 11(3):281-6. PubMed ID: 15174914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Initial clinical experience with a new percutaneous peripheral atherectomy device for the treatment of femoro-popliteal stenoses].
    Zeller T; Krankenberg H; Reimers B; Frank U; Bürgelin K; Schwarzwälder U; Neumann FJ
    Rofo; 2004 Jan; 176(1):70-5. PubMed ID: 14712409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease.
    Ansel GM; Botti CF; Silver Barry S George MJ; George BS
    J Invasive Cardiol; 2001 Aug; 13(8):608-10. PubMed ID: 11481513
    [No Abstract]   [Full Text] [Related]  

  • 57. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral drug-eluting technology.
    Franzone A; Stabile E; Trimarco B; Esposito G
    Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Stents in peripheral arterial occlusive diseases (PAOD)].
    Roeren T
    Ther Umsch; 2003 Apr; 60(4):199-203. PubMed ID: 12731429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.